Mast cell tumor history and symptoms: Difference between revisions

Jump to navigation Jump to search
Line 32: Line 32:
Skin symptoms
Skin symptoms
| style="padding: 5px 5px; background: #F5F5F5;" align=left |
| style="padding: 5px 5px; background: #F5F5F5;" align=left |
Pruritus
Most common in urticaria pigmentosa
*Pruritic cutaneous lesions
|-  
|-  
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; align=left" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; align=left" |

Revision as of 19:59, 2 March 2016

Mast cell tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mast Cell Tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Diagnostic criteria

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT Scan

MRI

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mast cell tumor history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mast cell tumor history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mast cell tumor history and symptoms

CDC on Mast cell tumor history and symptoms

Mast cell tumor history and symptoms in the news

Blogs on Mast cell tumor history and symptoms

Directions to Hospitals Treating Mast cell tumor

Risk calculators and risk factors for Mast cell tumor history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

History and Symptoms

Clinical pattern depends on mast cells burden in different organs and release of clinically relevant mediators such as histamine, leukotrienes, tryptase, and heparin.[1] There is considerable heterogeneity in the presentation of mastocytosis, and in the rate of disease progression. Clinical features include:[2]

  • Pruritic cutaneous lesions
  • Flushing
  • Itching
  • Rhinorrhea
  • Abdominal cramping
  • Wheezing
  • Headache
  • Dyspnea
  • Nausea
  • Vomiting
  • Diarrhea
  • Hypotension and syncope
  • Abdominal pain
  • Malabsorption
  • Bone pain and pathological fractures
  • Weight loss
  • Fever and night sweats
Type Symptoms

Skin symptoms

Most common in urticaria pigmentosa

  • Pruritic cutaneous lesions

Mast cell reslease symptoms

Observed in both cutaneous mastocytosis and systemic mastocytosis

  • Hypotension
  • Flushing
  • Itching
  • Syncope
  • Abdominal discomfort
  • Vomiting
  • Diarrhea

Upper urinary tract transitional cell cancer after cystectomy

2 - 9%



Urticaria Pigmentosa

  • Urticaria pigmentosa is the most common clinical variant in which fixed, reddish brown lesions occurring as maculo-papules, plaques, nodules, or blisters are found.[3]
  • These lesions urticate in response to physical irritation (Darier’s sign).
  • Urticaria Pigmentosa (UP) lesions tend to be larger, better delineated, and more hyperpigmented in children, as compared to adults, who tend to have numerous small lesions that coalesce to form mottled areas.
  • The trunk and thigh are more commonly involved with sparing of face, palms and soles.

Diffuse Cutaneous Mastocytosis

  • Diffuse cutaneous mastocytosis is a rare variant of childhood mastocytosis that appears as diffuse infiltrative yellow-orange xanthogranuloma-like subcutaneous nodules, or as a widespread urticarial eruption with bullae and redness.
  • The clinical course is more severe and can even be life-threatening, due to hypovolemic shock, mast cell leukemia, gastrointestinal hemorrhage, and cachexia[3]

Kinetics of blood clotting may be altered due to fibrinogenolytic and anticoagulant activities of tryptase and heparin respectively. Severe bleeding leading to the death of a patient with systemic mastocytosis due to heparin-like anticoagulant has been recently reported, and may represent a difficult diagnosis and a therapeutic challenge in the emergency room.[1]

References

  1. 1.0 1.1 Koenig, Martial; Morel, Jérôme; Reynaud, Jacqueline; Varvat, Cécile; Cathébras, Pascal (2008). "An unusual cause of spontaneous bleeding in the intensive care unit – mastocytosis: a case report". Cases Journal. 1 (1): 100. doi:10.1186/1757-1626-1-100. ISSN 1757-1626.
  2. Mastocytosis. Dr Alexandra Stanislavsky. Radiopaedia.org 2015. http://radiopaedia.org/articles/mastocytosis Accessed on February 29, 2016
  3. 3.0 3.1 Ferrante, Giuliana; Scavone, Valeria; Muscia, Maria; Adrignola, Emilia; Corsello, Giovanni; Passalacqua, Giovanni; La Grutta, Stefania (2015). "The care pathway for children with urticaria, angioedema, mastocytosis". World Allergy Organization Journal. 8 (1): 5. doi:10.1186/s40413-014-0052-x. ISSN 1939-4551.

Template:WH Template:WS